WOBURN, Mass., Jan. 6, 2011 /PRNewswire/ — The Center for
Business Intelligence (CBI) is pleased to announce Preclinical and
Clinical Imaging for Drug Development being held February 23, 2011
from 9:30 am – 6:00 pm EST. CBI provides a unique opportunity to
bring together a diverse collection of imaging experts from around
the world to discuss the very latest imaging technologies relevant
to today’s practitioners in a virtual conference environment.
This inaugural virtual conference will provide cutting-edge
insights and practical information on the latest developments
affecting this rapidly evolving field. This conference offers an
understanding of the importance of R&D into novel therapies and
discusses the application of current and innovative imaging
technologies and developments in oncology, CNS and cardiovascular
therapeutic areas. This conference will also examine the importance
of translational studies and how to bridge the preclinical to
clinical divide while emphasizing how to develop and incorporate
imaging solutions that lead to earlier diagnosis.
Confirmed speakers include:
Peter Conti, MD, PhD, Professor of Radiology, Biomedical
Engineering and Pharmacy, USC, Los Angeles, CA Gregory Goldmacher,
MD, PhD, Assistant Director, Medical Affairs, ICON Medical Imaging
Neeta Fahey, Associate Director, Clinical Imaging and Technologies,
Pfizer Inc. Zachary H. Levine, Physicist, National Institute of
Standards and Technology Thomas Bocan, PhD, Senior Director, Head
of BioImaging Center, Pharma Therapeutics Research &
Development, Pfizer Inc. Jacek Capala, PhD, Radiation Oncology
Branch, NIH/NCI Jasper Lee, Dept. of Biomedical Engineering,
University of Southern California
CBI is a subsidiary of Advanstar Communications Inc, and
develops market-driven, unbiased conferences in the fields of
pharmaceuticals and biotech, medical devices, and managed care
markets. CBI cr
‘/>”/>
